06
Nov
Nov
A recent study reveals how C210, a curcumin derivative, selectively reactivates the Epstein-Barr virus to kill cancer cells without the risk of infection, paving the way for safer, targeted cancer therapies. Study: Curcumin derivative C210 induces the Epstein-Barr virus lytic cycle and inhibits virion production by interfering with Hsp90 function. Photo credit: Stephanie Frey / […]